A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

about

A multicenter, open-label, phase III study of Abcertin in Gaucher disease: Erratum

P2860

Q58768857-B650831D-CBB9-4CAB-9614-F57EC73921D9

P2860

A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

Item

http://www.wikidata.org/entity/Q47143887

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

@en

A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

@nl

type

Item

label

A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

@en

A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

@nl

prefLabel

A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

@en

A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

@nl

P1476

A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

@en

P2093

Ahmed Fathy Abdalla

http://www.w3.org/2001/XMLSchema#string

Amal El Beshlawy

http://www.w3.org/2001/XMLSchema#string

Beom Hee Lee

http://www.w3.org/2001/XMLSchema#string

Ekram Fateen

http://www.w3.org/2001/XMLSchema#string

Gu-Hwan Kim

http://www.w3.org/2001/XMLSchema#string

Han-Wook Yoo

http://www.w3.org/2001/XMLSchema#string

Jin-Ho Choi

http://www.w3.org/2001/XMLSchema#string

June-Young Park

http://www.w3.org/2001/XMLSchema#string

Mona Abdel Latif Elsayed

http://www.w3.org/2001/XMLSchema#string

Mona Hassan El-Tagui

http://www.w3.org/2001/XMLSchema#string

P2860

Enzyme replacement in Gaucher disease

The long-term international safety experience of imiglucerase therapy for Gaucher disease

Individualization of long-term enzyme replacement therapy for Gaucher disease.

Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease.

Revised recommendations for the management of Gaucher disease in children.

Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment

Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model.

Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages.

Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease

A phase 2 multi-center, open-label, switch-over trial to evaluate the safety and efficacy of Abcertin® in patients with type 1 Gaucher disease.

P304

e8492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000008492

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ahmed Megahed

Khaled Eid

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29137040

http://www.w3.org/2001/XMLSchema#string

P932

5690733

http://www.w3.org/2001/XMLSchema#string

A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

about

P2860

P2860

A multicenter, open-label, phase III study of Abcertin in Gaucher disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932